Praxis Precision Medicines, Inc. (PRAX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Praxis Precision Medicines (PRAX) Q1 2026: $474M Cash Infusion Extends Runway as Dual Launches Near
May 07, 2026
-
Praxis (PRAX) Q4 2025: $1.5B Cash Fuels Dual NDA Launches and $20B CNS Ambition
February 23, 2026
-
Praxis (PRAX) Q2 2025: $411M Cash Extends Runway, Four Registration Programs Set for 2025
August 04, 2025